ACTINIUM PHARMACEUTICALS, INC. Other Current Liabilities
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Other Current Liabilities of $91.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2023-03-31
- 2022-09-30: Other Liabilities, Current $91.00K.
- 2022-06-30: Other Liabilities, Current $204.00K.
- 2022-03-31: Other Liabilities, Current $267.00K.
- 2021-12-31: Other Liabilities, Current $998.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2022-09-30 | $91.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $204.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $267.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $998.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |